94702 ⎘
Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms 1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms
Sub-classes:METHODS FOR PRODUCING VILOXAZINE SALTS AND NOVEL POLYMORPHS THEREOF
#2SUBSTITUTED NAPHTHYL P38ALPHA MITOGEN-ACTIVATED PROTEIN KINASE INHIBITORS
#3ANTI-INFLAMMATORY AND ANALGESIC COMPOUNDS AND USE THEREOF
#4CLEAVABLE LINKER-CONTAINING IONIZABLE LIPIDS AND LIPID CARRIERS FOR THERAPEUTIC COMPOSITIONS
#5NAMPT MODULATORS
#6SUBSTITUTED NAPHTHYL P38ALPHA MITOGEN-ACTIVATED PROTEIN KINASE INHIBITORS
#7Process for decontamination of hazardous sulfur compounds in sour water tanks
#8SILICON COMPOUND AND METHOD OF MANUFACTURING INTEGRATED CIRCUIT DEVICE USING THE SAME
#9LACTAM COMPOUNDS AS Kv1.3 POTASSIUM SHAKER CHANNEL BLOCKERS
#10Substituted naphthyl p38alpha mitogen-activated protein kinase inhibitors
#11AMINO ACID-, PEPTIDE- AND POLYPEPTIDE-LIPIDS, ISOMERS, COMPOSITIONS, AND USES THEREOF
#12QUATERNARY HETEROATOM CONTAINING COMPOUNDS
#13NURR1 RECEPTOR MODULATORS
#14SUBSTITUTED, SATURATED AND UNSATURATED N-HETEROCYCLIC CARBOXAMIDES AND RELATED COMPOUNDS FOR THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS
#15Substituted naphthyl p38α mitogen-activated protein kinase inhibitors
#16Decarboxylase inhibitors for treating Parkinson's disease
#17QUATERNARY AMMONIUM SALTS AS INHIBITORS OF TRIMETHYLAMINE PRODUCTION
#18METHODS FOR PRODUCING VILOXAZINE SALTS AND NOVEL POLYMORPHS THEREOF
#19Quaternary heteroatom containing compounds
#20Process for decontamination of hazardous sulfur compounds in sour water tanks
#21Amino acid-, peptide- and polypeptide-lipids, isomers, compositions, and uses thereof
#22Intermediates useful for the synthesis of aminopyrimidine derivatives, process for preparing the same, and process for preparing aminopyrimidine derivatives using the same
#23Hydrofluorocarboximidate and methods of making and using the same
#24Quaternary heteroatom containing compounds
#25Enantioselective synthesis of α-quaternary Mannich adducts by palladium-catalyzed allylic alkylation
#26Building blocks for stapled peptides
#27METHODS FOR PRODUCING VILOXAZINE SALTS AND NOVEL POLYMORPHS THEREOF
#28POLYMERIZABLE COMPOSITION COMPRISING AN OXIME SULFONATE AS THERMAL CURING AGENT
#29Amino acid-, peptide- and polypeptide-lipids, isomers, compositions, and uses thereof
#30CIS-morpholinone and other compounds as MDM2 inhibitors for the treatment of cancer
#31Quaternary heteroatom containing compounds
#32Process for decontamination of hazardous sulfur compounds in sour water tanks
#33Methods for producing viloxazine salts and novel polymorphs thereof
#34DERIVATIVES OF BETULIN
#35Hepatitis B antiviral agents
#36Process for preparing a polymorph of rivaroxaban
#37Preparation method for benzoxazoleoxazine ketone compound and intermediate and crystal form thereof
#38Process for the Preparation of Rivaroxaban
#39Compounds and compositions for treating HIV with derivatives of Betulin
#40Quaternary heteroatom containing compounds
#41Synthesis of therapeutic and diagnostic drugs centered on regioselective and stereoselective ring opening of aziridinium ions
#42Methods for producing viloxazine salts and novel polymorphs thereof
#43Catalytic hydrogenation for producing amines from carboxylic acid amides, carboxylic acid diamides, di-, tri-, or polypeptides, or peptide amides
#44Process for the preparation of rivaroxaban
#45Enantioselective synthesis of α-quaternary mannich adducts by palladium-catalyzed allylic alkylation
#46ENANTIOSELECTIVE SYNTHESIS OF DIALKYLATED N,O-HETEROCYCLES BY PALLADIUM-CATALYZED ALLYLIC ALKYLATION
#47Polymerizable composition comprising an oxime sulfonate as thermal curing agent
#48Heteroaryl acid morpholinone compounds as MDM2 inhibitors for the treatment of cancer
#49CIS-MORPHOLINONE AND OTHER COMPOUNDS AS MDM2 INHIBITORS FOR THE TREATMENT OF CANCER
#50Hemi-aminal ethers and thioethers of N-alkenyl cyclic compounds
#51Cyclic amines as bromodomain inhibitors
#52Rivaroxaban intermediate and preparation thereof
#53Hepatitis B antiviral agents
#54Alpha hydroxy amides
#55(Thio)morpholine derivatives as S1P modulators
#56Derivatives of Betulin
#57Hepatitis B antiviral agents
#58Hydroxybupropion analogues for treating drug dependence
#59Viloxazine compositions
#604-substituent-2-hydroxylmorpholine-3-one and preparation method thereof
#61Compounds
#62Process for decontamination of hazardous sulfur compounds in sour water tanks
#63PROCESSES AND INTERMEDIATES FOR PREPARING RIVAROXABAN
#64Heterocyclic compounds as MDM2 inhibitors for the treatment of cancer
#65Method for the preparation of substituted oxazolidinones
#66Hepatitis B antiviral agents
#67Hepatitis B antiviral agents
#68Process for the preparation of a rivaroxaban and intermediates formed in said process
#69Cyclic amines as bromodomain inhibitors
#70Substituted morpholines as modulators for the calcium sensing receptor
#71Synthesis of therapeutic and diagnostic drugs centered on regioselective and stereoselective ring opening of aziridinium ions
#72Polymerizable composition comprising an oxime sulfonate as thermal curing agent
#73QUATERNARY HETEROATOM CONTAINING COMPOUNDS
#74COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF CANNABINOID RECEPTOR 1 ACTIVITY
#75Substituted 8-alkoxy-2-aminotetralin derivatives, and use thereof
#76Derivatives of betulin
#77PROCESSES FOR THE PREPARATION OF 4-MORPHOLIN-3-ONE
#78Amino acid-, peptide-and polypeptide-lipids, isomers, compositions, and uses thereof
#79Hydroxybupropion analogues for treating drug dependence
#80Preparation method of 5-[[2(R)-[1(R)-[3,5-bis(trifluoromethyl) phenyl]ethoxy]-3(S)-4-fluorophenyl-4-morpholinyl]methyl]-1,2-dihydro-3H-1,2,4-triazole-3-one
#81Processes for the preparation of rivaroxaban and intermediates thereof
#82Quaternary heteroatom containing compounds
#83ANTIFUNGAL COMPOUNDS
#84(Thio)morpholine derivatives as S1P modulators
#85Asymmetric synthesis of peptides
#86HALOALKYLSULFONANILIDE DERIVATIVE
#87Method for manufacturing dipeptidyl peptidase-IV inhibitor and intermediate
#88ASYMMETRIC SYNTHESIS OF PEPTIDES
#89INTERMEDIATE COMPOUND FOR SYNTHESIZING PHARMACEUTICAL AGENT AND PRODUCTION METHOD THEREOF
#90INTERMEDIATE COMPOUND FOR SYNTHESIZING PHARMACEUTICAL AGENT AND PRODUCTION METHOD THEREOF
#91Methods for producing viloxazine salts and novel polymorphs thereof
#92Substituted Aryl Sulfone Derivatives as Calcium Channel Blockers
#93Morpholinone compounds as factor IXA inhibitors
#94Preparation of aprepitant
#95Morpholinone compounds as factor IXa inhibitors
#96Processes for the preparation of rivaroxaban and intermediates thereof
#97PROCESS FOR PREPARING PYRIDONE DERIVATIVES 226
#98PREPARATION OF MORPHOLINE DERIVATIVES
#99Ruthenium Catalysts and Uses Thereof
#100Compounds Comprising a Cyclobutoxy Group
#101Processes for the preparation of rivaroxaban and intermediates thereof
#102Processes for the preparation of rivaroxaban and intermediates thereof
#103Carbonyl compounds
#104Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
#105Isophthalates as beta-secretase inhibitors
#106PROCESS FOR THE PREPARATION OF N-ARYLMORPHOLINONES
#107Lactam-substituted dicarboxylic acids and use thereof
#1085-substituted-2-phenylamino benzamides as MEK inhibitors
#109DIARYL MORPHOLINES AS CB1 MODULATORS
#110Oxazolidine and Morpholine Carboxamide Derivatives as P2X7 Modulators
#111NITROXIDES FOR LITHIUM-ION BATTERIES
#112Bupropion Metabolites and Methods of Their Synthesis and Use
#113HETEROCYLIC COMPOUNDS CONTAINING THE MORPHOLINE NUCLEUS THEIR PREPARATION AND USE
#114Unnatural amino acids capable of covalently modifying protein phosphatases and their use as general and specific inhibitors and probes
#115NOVEL METHOD FOR SYNTHESIS OF 1,4-MORPHOLINE-2,5-DIONES
#116Process for the preparation of aprepitant
#1175-Substituted-2-phenylamino benzamides as MEK inhibitors
#118Intermediate compound for synthesizing pharmaceutical agent and production method thereof
#119DEUTERIUM-ENRICHED RADAFAXINE
#120PROCESS FOR PREPARING 3-ACYLAMINOBENZOFURAN-2-CARBOXYLIC ACID DERIVATIVE
#121Resolution Process For Preparing (+)-2S,3S)-2-(3-Chlorophenyl)-3,3,3-Trimethyl-2-Morpholinol
#122Bridged aromatic substituted amine ligands with donor atoms
#123COMPOUNDS WITH ACTIVITY ON MUSCARINIC RECEPTORS
#1243-(2-acylamino-1-hydroxyethyl)-morpholine derivatives and their use as bace inhibitors
#125Phenylanine derivatives
#126Beta-Aminoacid-Derivatives As Factor Xa Inhibitors
#127Urea derivatives
#128New process for preparing an optically pure 2-morpholinol derivative
#129Enzyme-catalyzed dynamic kinetic resolution process for preparing (+)-(2s,3s)-2-(3-chlorophenyl)-3,5,5-trimethyl-2-morpholinoland salts and solvates thereof
#130Method for the production of 4-(4-aminophenyl)-3-morpholinone
#131Diastereomeric dynamic kinetic resolution process for preparing (+)-(2s,3s)-2-(3-chlorophenyl)-3,5,5-trimethyl-2-morpholinol, salts, and solvates thereof
#132Method for synthesizing esters of N-[(S)-1-carboxybutyl]-(S)-alanine and use thereof for synthesizing perindopril
#133Isophthalates as beta-secretase inhibitors
#134Process for the production of N-arylmorpholinones
#135β2-adrenergic receptor agonists
#136Carbonyl compounds
#137Process for producing 3-acylaminobenzofuran-2-carboxylic acid derivative
#138Ureas as factor Xa inhibitors
#139Thioureas as factor Xa inhibitors
#140Ethynyl derivatives as factor Xa inhibitors
#141Carboxamide derivatives and their use as factor Xa inhibitors
#142Intermediates of bupropion metabolites synthesis
#143Carboxamides
#144Bridged aromatic substituted amine ligands with donor atoms
#145Piperizinones as modulators of chemokine receptor activity
#146Aralkyl and aralkylidene heterocyclic lactam and imides
#147Process for 5-[[2(r)-[1(r)-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3(s)-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3h-1.,2,4-triazol-3-one
#148β2-adrenergic receptor agonists
#149Hydroxymorpholinone derivative and medicinal use thereof
#150Semicarbazide derivatives for combating thromboembolic diseases
#151Carboxamide derivatives
#152Piperidin-2-one derivative compounds and drugs containing these compounds as the active ingredient
#153Process for the preparation of 2-or-9-oxa-3, 7-diazabicyclo (3.3.1) nonanes from 2-aminomethyl-2, 3-dihydrooxazines intermediates therefore, and processes for preparing such intermediates